We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Approach Developed to Diagnose Tuberculosis

By LabMedica International staff writers
Posted on 25 Mar 2015
Print article
Image: StepOnePlus Real-Time Polymerase Chain Reaction (PCR) System (Photo courtesy of Applied Biosystems).
Image: StepOnePlus Real-Time Polymerase Chain Reaction (PCR) System (Photo courtesy of Applied Biosystems).
The diagnosis of pulmonary tuberculosis (TB) usually includes laboratory analysis of sputum, a viscous material derived from deep in the airways of patients with active disease which can be difficult to collect and analyze by microbiological and molecular techniques.

An alternative, less invasive sample matrix could greatly simplify TB diagnosis, and as Mycobacterium tuberculosis cells or DNA accumulate on the oral epithelia of pulmonary TB patients, these can be collected and detected by using oral (buccal) swabs.

Scientists at the University of Washington (Seattle, WA, USA) working with colleagues in South Africa, collected three swabs each from 20 subjects with active pulmonary TB and from 20 healthy controls. The swabs (OmniSwab, Whatman; Maidstone, UK) were brushed along the inside of the subject's cheek for about 10 seconds (7 to 8 times) to collect cells and saliva. The head of each swab was ejected into a tube containing suitable solutions.

Samples were tested by using a polymerase chain reaction (qPCR) specific to the M. tuberculosis IS6110 insertion element and qPCR was performed on the StepOnePlus Real-Time PCR system (Applied Biosystems; Foster City, CA, USA) using the protocol of initial incubation at 95 °C for 10 minutes and 45 cycles of 95 °C for 15 seconds (denaturation) and 60 °C for one minute (annealing/extension).

Upon testing by oral swab PCR (OSP), 18 of the 20 case subjects (90%) yielded at least two swabs positive for M. tuberculosis DNA either in partial volume or full volume analyses. Of the 60 swab samples collected from the case group, 44 (73.3%) were positive. All control subjects were negative in all three swab samples per subject, in both the partial volume and full volume analyses (OSP). Sputum smear (acid fast) microscopy results were available for 17 of the 20 case subjects, of which 10 (59%) were smear positive. Specificity of OSP was 100% relative to the presumed disease-negative status of healthy controls.

The authors stressed that the study is merely a proof of principle, limited by its small size. Efforts are under way to expand this initial study into a large-scale controlled trial. Yet the preliminary success offers hope for greatly improved TB detection and control, especially in nations with limited public health resources, OSP could simplify the molecular diagnosis of TB and potentially be used for active TB case finding, made possible by the simple, noninvasive nature of the sampling method. The study was published on March 2, 2015, in the journal Scientific Reports.

Related Links:

University of Washington
Whatman
Applied Biosystems 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: Molecular PCR-grade detection of Lyme bacteria right at the tick bite (Photo courtesy of En Carta Diagnostics)

Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes

Lyme disease, transmitted through tick bites, is a bacteria-caused illness that impacts 1.2 million individuals annually. The standard methods for diagnosing this disease include clinical examinations,... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more